18F-Fluorodeoxyglucose positron emission tomography/computed tomography in distinguishing pediatric clear cell sarcoma of the kidney from Wilms’ tumor
Pediatric Radiology · 2025
DOI: 10.1007/s00247-025-06239-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Radiology, 2025. Verfasst von Hui Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 1665 Kongjiang Road, 200092, China. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Kidney Neoplasms, Sarcoma, Clear Cell, Wilms Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
BACKGROUND: Clear cell sarcoma of the kidney is a rare primary renal malignancy in children and its differentiation from other renal tumors, particularly Wilms' tumor, poses significant diagnostic challenges. Notably, clear cell sarcoma of the kidney is associated with a poorer prognosis than Wilms' tumor, making the preoperative presumptive diagnosis critical for optimizing surgical resection and appropriate chemotherapy regimens. OBJECTIVE: We conducted a feasibility study to evaluate the diagnostic utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in distinguishing clear cell sarcoma of the kidney from Wilms' tumor. MATERIALS AND METHODS: This study included 19 patients diagnosed with clear cell sarcoma of the kidney and 84 patients with Wilms' tumor. Among these, 11/19 patients with clear cell sarcoma of the kidney and 28/84 patients of Wilms' tumor displayed positive findings on 18F-FDG PET/CT imaging, which were subsequently validated as tumor lesions by histologic examination, conventional imaging, or clinical follow-up. A retrospective analysis of the imaging features of clear cell sarcoma of the kidney and Wilms' tumor lesions on 18F-FDG PET/CT scans was conducted. Receiver operating characteristic (ROC) curve analyses were performed to determine the optimal cutoff of the maximum standardized uptake value (SUVmax) for diagnostic prediction. RESULTS: The mean SUVmax for all lesions of clear cell sarcoma of the kidney was significantly lower than that of Wilms' tumors (3.9 vs. 7.4; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 1665 Kongjiang Road, 200092, China.
- Chongming Hospital Affiliated to Shanghai University of Medicine and Health Sciences, Shanghai, China.
- Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 1665 Kongjiang Road, 200092, China. wanghui@xinhuamed.com.cn.
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 1665 Kongjiang Road, 200092, China. chengweiwei8416@xinhuamed.com.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Sun, H., Yang, Z., Jin, H., Cui, Y., Yin, Y., Chen, S., Fu, C., Wang, H., & Cheng, W. (2025). 18F-Fluorodeoxyglucose positron emission tomography/computed tomography in distinguishing pediatric clear cell sarcoma of the kidney from Wilms’ tumor. Pediatric Radiology. https://doi.org/10.1007/s00247-025-06239-w
Vancouver
Sun H, Yang Z, Jin H, Cui Y, Yin Y, Chen S, et al. 18F-Fluorodeoxyglucose positron emission tomography/computed tomography in distinguishing pediatric clear cell sarcoma of the kidney from Wilms’ tumor. Pediatric Radiology. 2025. doi:10.1007/s00247-025-06239-w
BibTeX
@article{Sun2025,
author = {Sun, Hui and Yang, Zhiyong and Jin, Hongfu and Cui, Yanfen and Yin, Yafu and Chen, Suyun and Fu, Chenglai and Wang, Hui and Cheng, Weiwei},
title = {18F-Fluorodeoxyglucose positron emission tomography/computed tomography in distinguishing pediatric clear cell sarcoma of the kidney from Wilms’ tumor},
journal = {Pediatric Radiology},
year = {2025},
doi = {10.1007/s00247-025-06239-w}
}
EUVIMED